Efficacy of Dexamethasone Added to Ramosetron for Preventing Postoperative Nausea and Vomiting in Highly Susceptible Patients Following Spine Surgery.

Trial Profile

Efficacy of Dexamethasone Added to Ramosetron for Preventing Postoperative Nausea and Vomiting in Highly Susceptible Patients Following Spine Surgery.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Feb 2012

At a glance

  • Drugs Dexamethasone (Primary) ; Ramosetron (Primary)
  • Indications Postoperative nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Feb 2012 Actual patient number changed from 100 to 94 as reported by ClinicalTrials.gov.
    • 19 Nov 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top